참고문헌 (60)

1. Biol. Pharm. Bull. M Abe 32 646 2009 10.1248/bpb.32.646 Abe M, Ito Y, Oyunzul L, Oki-Fujino T, Yamada S. Pharmacologically relevant receptor binding characteristics and 5alpha-reductase inhibitory activity of free fatty acids contained in saw palmetto extract. Biol. Pharm. Bull. 32: 646-650 (2009a) 

   상세보기

2. Anal. Sci. M Abe 25 553 2009 10.2116/analsci.25.553 Abe M, Ito Y, Suzuki A, Onoue S, Noguchi H, Yamada S. Isolation and pharmacological characterization of fatty acids from saw palmetto extract. Anal. Sci. 25: 553-557 (2009b) 

   상세보기

3. J. Herb Pharmacother. ML Anderson 5 17 2005 10.1080/J157v05n01_03 Anderson ML. A preliminary investigation of the enzymatic inhibition of 5alpha-reduction and growth of prostatic carcinoma cell line LNCaP-FGC by natural astaxanthin and saw palmetto lipid extract in vitro. J. Herb Pharmacother. 5: 17-26 (2005) 

   상세보기

4. Indian J. Exp. Biol. ML Arruzazabala 49 684 2011 Arruzazabala ML, Perez Y, Ravelo Y, Molina V, Carbajal D, Mas R, Rodriguez E. Effect of oleic, lauric and myristic acids on phenylephrine-induced contractions of isolated rat vas deferens. Indian J. Exp. Biol. 49: 684-688 (2011) 

   상세보기

5. Eur. J. Cancer Prev. AB Awad 10 507 2001 10.1097/00008469-200112000-00005 Awad AB, Fink CS, Williams H, Kim U. In vitro and in vivo (SCID mice) effects of phytosterols on the growth and dissemination of human prostate cancer PC-3 cells. Eur. J. Cancer Prev. 10: 507-513 (2001) 

   상세보기

6. BJU Int. A Baron 103 1275 2009 10.1111/j.1464-410X.2008.08266.x Baron A, Mancini M, Caldwell E, Cabrelle A, Bernardi P, Pagano F. Serenoa repens extract targets mitochondria and activates the intrinsic apoptotic pathway in human prostate cancer cells. BJU Int. 103: 1275-1283 (2009) 

   상세보기

7. JAMA MJ Barry 306 1344 2011 10.1001/jama.2011.1364 Barry MJ, Meleth S, Lee JY, Kreder KJ, Avins AL, Nickel JC, Roehrborn CG, Crawford ED, Foster HE, Jr., Kaplan SA, McCullough A, Andriole GL, Naslund MJ, Williams OD, Kusek JW, Meyers CM, Betz JM, Cantor A, McVary KT, CAMUS Study Group. Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: A randomized trial. JAMA 306: 1344-1351 (2011) 

   상세보기

8. N. Engl. J. Med. S Bent 354 557 2006 10.1056/NEJMoa053085 Bent S, Kane C, Shinohara K, Neuhaus J, Hudes ES, Goldberg H, Avins AL. Saw palmetto for benign prostatic hyperplasia. N. Engl. J. Med. 354: 557-566 (2006) 

   상세보기

9. BJU Int. RR Berges 85 842 2000 10.1046/j.1464-410x.2000.00672.x Berges RR, Kassen A, Senge T. Treatment of symptomatic benign prostatic hyperplasia with beta-sitosterol: An 18-month follow-up. BJU Int. 85: 842-846 (2000) 

   상세보기

10. Beta-sitosterol study group. Lancet RR Berges 345 1529 1995 Berges RR, Windeler J, Trampisch HJ, Senge T. Randomised, placebo-controlled, double-blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia. Beta-sitosterol study group. Lancet 345: 1529-1532 (1995) 

11. Prostate S Bernichtein 75 706 2015 10.1002/pros.22953 Bernichtein S, Pigat N, Camparo P, Latil A, Viltard M, Friedlander G, Goffin V. Anti-inflammatory properties of lipidosterolic extract of Serenoa repens (Permixon(R)) in a mouse model of prostate hyperplasia. Prostate 75: 706-722 (2015) 

    상세보기

12. J. Pharm. Pharmacol. A Booker 66 811 2014 10.1111/jphp.12198 Booker A, Suter A, Krnjic A, Strassel B, Zloh M, Said M, Heinrich M. A phytochemical comparison of saw palmetto products using gas chromatography and (1) H nuclear magnetic resonance spectroscopy metabolomic profiling. J. Pharm. Pharmacol. 66: 811-822 (2014) 

    상세보기

13. Br. J. Urol. BE Carbin 66 639 1990 10.1111/j.1464-410X.1990.tb07199.x Carbin BE, Larsson B, Lindahl O. Treatment of benign prostatic hyperplasia with phytosterols. Br. J. Urol. 66: 639-641 (1990) 

    상세보기

14. Br. J. Clin. Pharmacol. G Champault 18 461 1984 10.1111/j.1365-2125.1984.tb02491.x Champault G, Patel JC, Bonnard AM. A double-blind trial of an extract of the plant Serenoa repens in benign prostatic hyperplasia. Br. J. Clin. Pharmacol. 18: 461-462 (1984) 

    상세보기

15. Rev. Urol. B Chughtai 13 147 2011 Chughtai B, Lee R, Te A, Kaplan S. Role of inflammation in benign prostatic hyperplasia. Rev. Urol. 13: 147-150 (2011) 

    상세보기

16. Eur. Urol. F Debruyne 45 773 2004 10.1016/j.eururo.2004.01.015 Debruyne F, Boyle P, Calais Da Silva F, Gillenwater JG, Hamdy FC, Perrin P, Teillac P, Vela-Navarrete R, Raynaud JP, Schulman CC. Evaluation of the clinical benefit of permixon and tamsulosin in severe BPH patients-PERMAL study subset analysis. Eur. Urol. 45: 773-780 (2004) 

    상세보기

17. Prostate F Silverio Di 37 77 1998 10.1002/(SICI)1097-0045(19981001)37:2<77::AID-PROS3>3.0.CO;2-I Di Silverio F, Monti S, Sciarra A, Varasano PA, Martini C, Lanzara S, D’Eramo G, Di Nicola S, Toscano V. Effects of long-term treatment with Serenoa repens (Permixon) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasia. Prostate 37: 77-83 (1998) 

    상세보기

18. Rev. Urol. E Fagelman 3 134 2001 Fagelman E, Lowe FC. Saw palmetto berry as a treatment for BPH. Rev. Urol. 3: 134-138 (2001) 

19. Differentiation MR Freeman 82 244 2011 10.1016/j.diff.2011.04.005 Freeman MR, Solomon KR. Cholesterol and benign prostate disease. Differentiation 82: 244-252 (2011) 

    상세보기

20. BJU Int. G Gandaglia 112 432 2013 10.1111/bju.12118 Gandaglia G, Briganti A, Gontero P, Mondaini N, Novara G, Salonia A, Sciarra A, Montorsi F. The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH). BJU Int. 112: 432-441 (2013) 

    상세보기

21. Prostate M Goepel 38 208 1999 10.1002/(SICI)1097-0045(19990215)38:3<208::AID-PROS5>3.0.CO;2-4 Goepel M, Hecker U, Krege S, Rubben H, Michel MC. Saw palmetto extracts potently and noncompetitively inhibit human alpha1-adrenoceptors in vitro. Prostate 38: 208-215 (1999) 

    상세보기

22. Prostate Cancer Prostatic Dis. FK Habib 7 195 2004 10.1038/sj.pcan.4500746 Habib FK, Wyllie MG. Not all brands are created equal: A comparison of selected components of different brands of serenoa repens extract. Prostate Cancer Prostatic Dis. 7: 195-200 (2004) 

    상세보기

23. Anticancer Res. K Hostanska 27 873 2007 Hostanska K, Suter A, Melzer J, Saller R. Evaluation of cell death caused by an ethanolic extract of Serenoae repentis fructus (Prostasan) on human carcinoma cell lines. Anticancer Res. 27: 873-881 (2007) 

    상세보기

24. J. Steroid Biochem. Mol. Biol. C Iehle 54 273 1995 10.1016/0960-0760(95)00134-L Iehle C, Delos S, Guirou O, Tate R, Raynaud JP, Martin PM. Human prostatic steroid 5 alpha-reductase isoforms - a comparative study of selective inhibitors. J. Steroid Biochem. Mol. Biol. 54: 273-279 (1995) 

    상세보기

25. Br. J. Urol. KF Klippel 80 427 1997 10.1046/j.1464-410X.1997.t01-1-00362.x Klippel KF, Hiltl DM, Schipp B. A multicentric, placebo-controlled, double-blind clinical trial of beta-sitosterol (phytosterol) for the treatment of benign prostatic hyperplasia. German BPH-phyto study group. Br. J. Urol. 80: 427-432 (1997) 

    상세보기

26. Prostate A Latil 75 1857 2015 10.1002/pros.23059 Latil A, Petrissans MT, Rouquet J, Robert G, de la Taille A. Effects of hexanic extract of Serenoa repens (Permixon(R) 160 mg) on inflammation biomarkers in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia. Prostate 75: 1857-1867 (2015) 

    상세보기

27. Sci. Rep. SWH Lee 7 7984 2017 10.1038/s41598-017-06628-8 Lee SWH, Chan EMC, Lai YK. The global burden of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A systematic review and meta-analysis. Sci. Rep. 7: 7984 (2017) 

    상세보기

28. J. Urol. H Lepor 141 1283 1989 10.1016/S0022-5347(17)41282-1 Lepor H. Nonoperative management of benign prostatic hyperplasia. J. Urol. 141: 1283-1289 (1989) 

    상세보기

29. Rev. Urol. H Lepor 7 Suppl 4 S3 2005 Lepor H. Pathophysiology of benign prostatic hyperplasia in the aging male population. Rev. Urol. 7(Suppl 4): S3-S12 (2005) 

30. Rev. Urol. H Lepor 13 20 2011 Lepor H. Medical treatment of benign prostatic hyperplasia. Rev. Urol. 13: 20-33 (2011) 

    상세보기

31. Urol. Clin. North Am. H Lepor 43 311 2016 10.1016/j.ucl.2016.04.009 Lepor H. Alpha-blockers for the treatment of benign prostatic hyperplasia. Urol. Clin. North Am. 43: 311-323 (2016) 

    상세보기

32. Chem. Biodivers. J Liu 6 503 2009 10.1002/cbdv.200800125 Liu J, Shimizu K, Kondo R. Anti-androgenic activity of fatty acids. Chem. Biodivers. 6: 503-512 (2009) 

    상세보기

33. BJU Int. R MacDonald 109 1756 2012 10.1111/j.1464-410X.2012.11172.x MacDonald R, Tacklind JW, Rutks I, Wilt TJ. Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): An updated cochrane systematic review. BJU Int. 109: 1756-1761 (2012) 

    상세보기

34. BJU Int. VC Mishra 100 327 2007 10.1111/j.1464-410X.2007.06910.x Mishra VC, Allen DJ, Nicolaou C, Sharif H, Hudd C, Karim OM, Motiwala HG, Laniado ME. Does intraprostatic inflammation have a role in the pathogenesis and progression of benign prostatic hyperplasia? BJU Int. 100: 327-331 (2007) 

    상세보기

35. Eur. Urol. Focus. G Novara 2 553 2016 10.1016/j.euf.2016.04.002 Novara G, Giannarini G, Alcaraz A, Cozar-Olmo JM, Descazeaud A, Montorsi F, Ficarra V. Efficacy and safety of hexanic lipidosterolic extract of Serenoa repens (Permixon) in the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: systematic review and meta-analysis of randomized controlled trials. Eur. Urol. Focus. 2: 553-561 (2016) 

    상세보기

36. Evidence-Based Complementary and Alternative Medicine Alexander B. Opoku-Acheampong 2016 1 2016 10.1155/2016/8135135 Opoku-Acheampong AB, Penugonda K, Lindshield BL. Effect of saw palmetto supplements on androgen-sensitive LNCaP human prostate cancer cell number and syrian hamster flank organ growth. Evid.-Based Complement. Alternat. Med. 2016: 8135135 (2016) 

    상세보기

37. Nutrients K Penugonda 5 3617 2013 10.3390/nu5093617 Penugonda K, Lindshield BL. Fatty acid and phytosterol content of commercial saw palmetto supplements. Nutrients 5: 3617-3633 (2013) 

    상세보기

38. Adv. Ther. YA Pytel 19 297 2002 10.1007/BF02853175 Pytel YA, Vinarov A, Lopatkin N, Sivkov A, Gorilovsky L, Raynaud JP. Long-term clinical and biologic effects of the lipidosterolic extract of Serenoa repens in patients with symptomatic benign prostatic hyperplasia. Adv. Ther. 19: 297-306 (2002) 

    상세보기

39. J. Steroid Biochem. Mol. Biol. JP Raynaud 82 233 2002 10.1016/S0960-0760(02)00187-5 Raynaud JP, Cousse H, Martin PM. Inhibition of type 1 and type 2 5alpha-reductase activity by free fatty acids, active ingredients of Permixon. J. Steroid Biochem. Mol. Biol. 82: 233-239 (2002) 

    상세보기

40. Br. J. Urol. H Reece Smith 58 36 1986 10.1111/j.1464-410X.1986.tb05424.x Reece Smith H, Memon A, Smart CJ, Dewbury K. The value of Permixon in benign prostatic hypertrophy. Br. J. Urol. 58: 36-40 (1986) 

    상세보기

41. Prostate L Rhodes 22 43 1993 10.1002/pros.2990220107 Rhodes L, Primka RL, Berman C, Vergult G, Gabriel M, Pierre-Malice M, Gibelin B. Comparison of finasteride (Proscar), a 5 alpha reductase inhibitor, and various commercial plant extracts in in vitro and in vivo 5 alpha reductase inhibition. Prostate 22: 43-51 (1993) 

    상세보기

42. Rev. Urol. CG Roehrborn 7 Suppl 9 S3 2005 Roehrborn CG. Benign prostatic hyperplasia: An overview. Rev. Urol. 7(Suppl 9): S3-S14 (2005) 

43. Arab J. Urol. F Saad 9 147 2011 10.1016/j.aju.2011.06.003 Saad F, Yassin AA, Haider A, Gooren L. Effects of testosterone on the lower urinary tract go beyond the prostate: New insights, new treatment options. Arab J. Urol. 9: 147-152 (2011) 

    상세보기

44. Eur. Rev. Med. Pharmacol. Sci. F Scaglione 16 569 2012 Scaglione F, Lucini V, Pannacci M, Dugnani S, Leone C. Comparison of the potency of 10 different brands of Serenoa repens extracts. Eur. Rev. Med. Pharmacol. Sci. 16: 569-574 (2012) 

    상세보기

45. Biochem. Biophys. Res. Commun. C Scholtysek 379 795 2009 10.1016/j.bbrc.2008.11.114 Scholtysek C, Krukiewicz AA, Alonso JL, Sharma KP, Sharma PC, Goldmann WH. Characterizing components of the saw palmetto berry extract (SPBE) on prostate cancer cell growth and traction. Biochem. Biophys. Res. Commun. 379: 795-798 (2009) 

    상세보기

46. J. Inflamm. I Silvestri 10 11 2013 10.1186/1476-9255-10-11 Silvestri I, Cattarino S, Agliano A, Nicolazzo C, Scarpa S, Salciccia S, Frati L, Gentile V, Sciarra A. Effect of Serenoa repens (Permixon(R)) on the expression of inflammation-related genes: Analysis in primary cell cultures of human prostate carcinoma. J. Inflamm. 10: 11 (2013) 

    상세보기

47. Urol. Int. I Sinescu 86 284 2011 10.1159/000322645 Sinescu I, Geavlete P, Multescu R, Gangu C, Miclea F, Coman I, Ioiart I, Ambert V, Constantin T, Petrut B, Feciche B. Long-term efficacy of Serenoa repens treatment in patients with mild and moderate symptomatic benign prostatic hyperplasia. Urol. Int. 86: 284-289 (2011) 

    상세보기

48. Eur. Urol. G Strauch 26 247 1994 10.1159/000475388 Strauch G, Perles P, Vergult G, Gabriel M, Gibelin B, Cummings S, Malbecq W, Malice MP. Comparison of finasteride (Proscar) and Serenoa repens (Permixon) in the inhibition of 5-alpha reductase in healthy male volunteers. Eur. Urol. 26: 247-252 (1994) 

    상세보기

49. J. Steroid Biochem. C Sultan 20 515 1984 10.1016/0022-4731(84)90264-4 Sultan C, Terraza A, Devillier C, Carilla E, Briley M, Loire C, Descomps B. Inhibition of androgen metabolism and binding by a liposterolic extract of “Serenoa repens B” in human foreskin fibroblasts. J. Steroid Biochem. 20: 515-519 (1984) 

    상세보기

50. Acta Pharmacol. Sin. M Suzuki 30 227 2009 10.1038/aps.2009.1 Suzuki M, Ito Y, Fujino T, Abe M, Umegaki K, Onoue S, Noguchi H, Yamada S. Pharmacological effects of saw palmetto extract in the lower urinary tract. Acta Pharmacol. Sin. 30: 227-281 (2009) 

    상세보기

51. Urology M Suzuki 69 1216 2007 10.1016/j.urology.2007.02.038 Suzuki M, Oki T, Sugiyama T, Umegaki K, Uchida S, Yamada S. Muscarinic and alpha 1-adrenergic receptor binding characteristics of saw palmetto extract in rat lower urinary tract. Urology 69: 1216-1220 (2007) 

    상세보기

52. Cochrane Database Syst. Rev. J Tacklind 12 CD001423 2012 Tacklind J, Macdonald R, Rutks I, Stanke JU, Wilt TJ. Serenoa repens for benign prostatic hyperplasia. Cochrane Database Syst. Rev. 12: CD001423 (2012) 

53. Mol. Cell Biochem. N Talpur 250 21 2003 10.1023/A:1024988929454 Talpur N, Echard B, Bagchi D, Bagchi M, Preuss HG. Comparison of saw palmetto (extract and whole berry) and cernitin on prostate growth in rats. Mol. Cell Biochem. 250: 21-26 (2003) 

    상세보기

54. BJU Int. R Vela-Navarrete 122 1049 2018 10.1111/bju.14362 Vela-Navarrete R, Alcaraz A, Rodriguez-Antolin A, Minana Lopez B, Fernandez-Gomez JM, Angulo JC, Castro Diaz D, Romero-Otero J, Brenes FJ, Carballido J, Molero Garcia JM, Fernandez-Pro Ledesma A, Cozar Olmos JM, Manasanch Dalmau J, Subirana Cachinero I, Herdman M, Ficarra V. Efficacy and safety of a hexanic extract of Serenoa repens (Permixon((R))) for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH): Systematic review and meta-analysis of randomised controlled trials and observational studies. BJU Int. 122: 1049-1065 (2018) 

    상세보기

55. J. Urol. R Vela-Navarrete 173 507 2005 10.1097/01.ju.0000150533.94952.25 Vela-Navarrete R, Escribano-Burgos M, Farre AL, Garcia-Cardoso J, Manzarbeitia F, Carrasco C. Serenoa repens treatment modifies bax/bcl-2 index expression and caspase-3 activity in prostatic tissue from patients with benign prostatic hyperplasia. J. Urol. 173: 507-510 (2005) 

    상세보기

56. Urologia Journal Andrey Zinovievich Vinarov 86 1 17 2018 10.1177/0391560318772466 Vinarov AZ, Spivak LG, Platonova DV, Rapoport LM, Korolev DO. 15 years’ survey of safety and efficacy of Serenoa repens extract in benign prostatic hyperplasia patients with risk of progression. Urologia https://doi.org/10.1177/0391560318772466 (2018) 

    상세보기

57. Nutr. Cancer. RL Holtz von 32 8 1998 10.1080/01635589809514709 von Holtz RL, Fink CS, Awad AB. Beta-sitosterol activates the sphingomyelin cycle and induces apoptosis in lncap human prostate cancer cells. Nutr. Cancer. 32: 8-12 (1998) 

    상세보기

58. Endocrinology TL Wadsworth 145 3205 2004 10.1210/en.2003-1716 Wadsworth TL, Carroll JM, Mallinson RA, Roberts CT, Jr., Roselli CE. Saw palmetto extract suppresses insulin-like growth factor-I signaling and induces stress-activated protein kinase/c-Jun N-terminal kinase phosphorylation in human prostate epithelial cells. Endocrinology 145: 3205-3214 (2004) 

    상세보기

59. Prostate H Weisser 28 300 1996 10.1002/(SICI)1097-0045(199605)28:5<300::AID-PROS5>3.0.CO;2-F Weisser H, Tunn S, Behnke B, Krieg M. Effects of the sabal serrulata extract IDS 89 and its subfractions on 5 alpha-reductase activity in human benign prostatic hyperplasia. Prostate 28: 300-306 (1996) 

    상세보기

60. Cochrane Database Syst. Rev. T Wilt 3 CD001423 2002 Wilt T, Ishani A, Mac Donald R. Serenoa repens for benign prostatic hyperplasia. Cochrane Database Syst. Rev. 3: CD001423 (2002)